Tetrahydrocoptisine
CAS: 4312-32-7
Ref. TM-T4S2063
1mg | 52,00 € | ||
5mg | 94,00 € | ||
10mg | 150,00 € | ||
25mg | 245,00 € | ||
50mg | 362,00 € | ||
100mg | 533,00 € |
Información del producto
- STYLOPINE
- (RS)-Stylopine
- (S)-stylopine
- (±)-Stylopine
- 2,3:9,10-Bis(methylenedioxy)-13a-berbine
- 2,3:9,10-Bis(methylenedioxy)berbine
- 4H-Bis[1,3]benzodioxolo[5,6-a:4′,5′-g]quinolizine, 6,7,12b,13-tetrahydro-
- 4H-[1,3]benzodioxolo[5,6-a]-1,3-benzodioxolo[4,5-g]quinolizine, 6,7,12b,13-tetrahydro-
- 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine
- 6,7,12b,13-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4′,5′-g]quinolizine
- Ver más sinónimos
- 7461-02-1
- Berbine, 2,3:9,10-bis(methylenedioxy)-, (±)-
- Chelidamine
- NSC 110382
- NSC 404529
- Stylopine (VAN)
- dl-Stylopine
- dl-Tetrahydrocoptisine
1. Tetrahydrocoptisine (STYLOPINE) has effective effects in suppressing inflammation. 2. Tetrahydrocoptisine possesses a protective effect on LPS-induced ALI through inhibiting of NF-κB signaling pathways, which may involve the inhibition of pulmonary inflammatory process. 3. Tetrahydrocoptisine has gastroprotective activity, is attributed to reducing NO production and adjusting the pro-inflammatory cytokine, inhibited neutrophil accumulation and NF-κB expression. 4. Tetrahydrocoptisine is an active anti-inflammatory constituent by inhibition of TNF-α, IL-6 and NO production possibly via down-regulation of NF-κB activation, phospho-ERK1/2 and phospho-p38MAPK signal pathways.
Propiedades químicas
Consulta técnica sobre: TM-T4S2063 Tetrahydrocoptisine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.